Hartig Drug Company has expanded its product lineup by adding Nefense® nasal care products at select locations in Iowa, Illinois, and Wisconsin, offering customers new drug-free options for daily nasal hygiene. The move responds to growing consumer interest in non-medicated alternatives for nasal care, particularly among families seeking gentle solutions for adults, children, and even infants.
The Nefense lineup features hypochlorous acid nasal sprays designed for different age groups—HypoNasal for adults, HypoNasal Junior for children, and HypoBaby for infants—as well as XyloClean, a xylitol-based spray. These products provide non-medicated alternatives to decongestants, which can be appealing for those who prefer to avoid active pharmaceutical ingredients or who need long-term daily maintenance without the risk of rebound congestion.
Published randomized clinical research has evaluated low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms and allergic rhinitis, demonstrating its potential efficacy in managing these conditions. Although these studies do not test Nefense-branded products specifically, the underlying science supports the mechanism of action for hypochlorous acid in nasal care. This research adds credibility to the product category, reassuring customers who are cautious about new health products.
The availability of Nefense products in Hartig Drug stores is significant because it brings clinically studied, drug-free options directly to local communities. Hartig Drug, a family-owned company founded in Dubuque, Iowa, in 1904, has a long-standing reputation for personalized service and community engagement. By adding Nefense, they are responding to a growing demand for preventive health and wellness products that complement traditional pharmacy services.
Nefense, based in Dubuque, Iowa, developed its formulations under the direction of Richard Downs, DDS. The company’s focus on daily nasal hygiene and airway care aligns with broader public health trends that emphasize proactive management of respiratory health. For customers, this means access to products that could help reduce reliance on antibiotics or decongestants, potentially lowering healthcare costs and improving quality of life.
The decision to introduce these products at select stores in three states suggests a strategic rollout, likely to gauge consumer response before wider distribution. As healthcare continues to shift toward preventive and self-care approaches, partnerships between innovative wellness brands and established retail pharmacies like Hartig Drug are likely to become more common. This collaboration exemplifies how local businesses can bring novel, science-backed solutions to their communities, enhancing their role as health destinations beyond mere prescription fulfillment.
For those interested in exploring these new options, the products are available now at participating Hartig Drug locations. More information about Nefense can be found at nefense.com, and the full press release is accessible via this link. As always, customers are encouraged to consult with their healthcare providers when adding new products to their wellness routines, especially for children and infants.
